DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.01% | -0.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.15% | 13.77% | |||
| Operating Income | -0.15% | -13.77% | |||
| Income Before Tax | -0.97% | -14.95% | |||
| Income Tax Expenses | 0.00% | -30.00% | |||
| Earnings from Continuing Operations | -0.97% | -14.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.97% | -14.90% | |||
| EBIT | -0.15% | -13.77% | |||
| EBITDA | -0.14% | -13.79% | |||
| EPS Basic | -0.75% | -12.00% | |||
| Normalized Basic EPS | -0.77% | -12.01% | |||
| EPS Diluted | -0.75% | -12.00% | |||
| Normalized Diluted EPS | -0.77% | -12.01% | |||
| Average Basic Shares Outstanding | 0.19% | 2.63% | |||
| Average Diluted Shares Outstanding | 0.19% | 2.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||